SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY
In an embodiment, the present disclosure pertains to a composition to enhance efficacy of a pharmaceutical agent. In some embodiments, the composition includes a synthetic lysine analog, derivative, mimetic, or prodrog and the pharmaceutical agent. In some embodiments, the synthetic lysine analog, d...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | STEWART, W. Paul MURDOCK, Frank |
| description | In an embodiment, the present disclosure pertains to a composition to enhance efficacy of a pharmaceutical agent. In some embodiments, the composition includes a synthetic lysine analog, derivative, mimetic, or prodrog and the pharmaceutical agent. In some embodiments, the synthetic lysine analog, derivative, mimetic, or prodrug and the antiviral agent form a synergistic combination. In an additional embodiment, the present disclosure pertains to a method to enhance efficacy of the pharmaceutical agent that generally includes administering the synergistic combination to a subject in need thereof. In a further embodiment, the present disclosure pertains to a kit to enhance efficacy of the pharmaceutical agent that generally includes the synergistic combination. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA202205867B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA202205867B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA202205867B3</originalsourceid><addsrcrecordid>eNqNyk0KwjAQhuFuXIh6h3GvUCr-bKfppAk0SUnSQt2UInElWqiH8Nim4AFczTe8zzL5uE6TLaXzkgEzKpcavTTageEQmxc0l6pzUhOgxsqUbgcFWdlG2FJ8lFQzistYqK0pbFO6aAuoBVqFjJqYsQIsSXsHPDLSAjWjAojz2Fi3Thb34TGFze-uki0nz8Q-jK8-TONwC8_w7q-YpVmWHi-nc374x3wBkIE-kw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY</title><source>esp@cenet</source><creator>STEWART, W. Paul ; MURDOCK, Frank</creator><creatorcontrib>STEWART, W. Paul ; MURDOCK, Frank</creatorcontrib><description>In an embodiment, the present disclosure pertains to a composition to enhance efficacy of a pharmaceutical agent. In some embodiments, the composition includes a synthetic lysine analog, derivative, mimetic, or prodrog and the pharmaceutical agent. In some embodiments, the synthetic lysine analog, derivative, mimetic, or prodrug and the antiviral agent form a synergistic combination. In an additional embodiment, the present disclosure pertains to a method to enhance efficacy of the pharmaceutical agent that generally includes administering the synergistic combination to a subject in need thereof. In a further embodiment, the present disclosure pertains to a kit to enhance efficacy of the pharmaceutical agent that generally includes the synergistic combination.</description><language>eng</language><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230125&DB=EPODOC&CC=ZA&NR=202205867B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230125&DB=EPODOC&CC=ZA&NR=202205867B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STEWART, W. Paul</creatorcontrib><creatorcontrib>MURDOCK, Frank</creatorcontrib><title>SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY</title><description>In an embodiment, the present disclosure pertains to a composition to enhance efficacy of a pharmaceutical agent. In some embodiments, the composition includes a synthetic lysine analog, derivative, mimetic, or prodrog and the pharmaceutical agent. In some embodiments, the synthetic lysine analog, derivative, mimetic, or prodrug and the antiviral agent form a synergistic combination. In an additional embodiment, the present disclosure pertains to a method to enhance efficacy of the pharmaceutical agent that generally includes administering the synergistic combination to a subject in need thereof. In a further embodiment, the present disclosure pertains to a kit to enhance efficacy of the pharmaceutical agent that generally includes the synergistic combination.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyk0KwjAQhuFuXIh6h3GvUCr-bKfppAk0SUnSQt2UInElWqiH8Nim4AFczTe8zzL5uE6TLaXzkgEzKpcavTTageEQmxc0l6pzUhOgxsqUbgcFWdlG2FJ8lFQzistYqK0pbFO6aAuoBVqFjJqYsQIsSXsHPDLSAjWjAojz2Fi3Thb34TGFze-uki0nz8Q-jK8-TONwC8_w7q-YpVmWHi-nc374x3wBkIE-kw</recordid><startdate>20230125</startdate><enddate>20230125</enddate><creator>STEWART, W. Paul</creator><creator>MURDOCK, Frank</creator><scope>EVB</scope></search><sort><creationdate>20230125</creationdate><title>SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY</title><author>STEWART, W. Paul ; MURDOCK, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA202205867B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>STEWART, W. Paul</creatorcontrib><creatorcontrib>MURDOCK, Frank</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STEWART, W. Paul</au><au>MURDOCK, Frank</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY</title><date>2023-01-25</date><risdate>2023</risdate><abstract>In an embodiment, the present disclosure pertains to a composition to enhance efficacy of a pharmaceutical agent. In some embodiments, the composition includes a synthetic lysine analog, derivative, mimetic, or prodrog and the pharmaceutical agent. In some embodiments, the synthetic lysine analog, derivative, mimetic, or prodrug and the antiviral agent form a synergistic combination. In an additional embodiment, the present disclosure pertains to a method to enhance efficacy of the pharmaceutical agent that generally includes administering the synergistic combination to a subject in need thereof. In a further embodiment, the present disclosure pertains to a kit to enhance efficacy of the pharmaceutical agent that generally includes the synergistic combination.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA202205867B |
| source | esp@cenet |
| title | SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STEWART,%20W.%20Paul&rft.date=2023-01-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA202205867B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |